nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Carbetocin—OXTR—lung cancer	0.0241	0.972	CrCbGaD
Terlipressin—AVPR1A—respiratory system—lung cancer	0.00847	0.357	CbGeAlD
Terlipressin—AVPR2—respiratory system—lung cancer	0.00702	0.296	CbGeAlD
Terlipressin—AVPR1A—lung—lung cancer	0.0045	0.19	CbGeAlD
Terlipressin—AVPR2—lung—lung cancer	0.00373	0.157	CbGeAlD
Terlipressin—Cardiac failure—Vinorelbine—lung cancer	0.00243	0.00481	CcSEcCtD
Terlipressin—Skin disorder—Crizotinib—lung cancer	0.00242	0.00478	CcSEcCtD
Terlipressin—Hypertension—Pemetrexed—lung cancer	0.0024	0.00476	CcSEcCtD
Terlipressin—Hyponatraemia—Vinorelbine—lung cancer	0.00238	0.00472	CcSEcCtD
Terlipressin—Chest pain—Pemetrexed—lung cancer	0.00237	0.00469	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Pemetrexed—lung cancer	0.00235	0.00466	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Gefitinib—lung cancer	0.00234	0.00463	CcSEcCtD
Terlipressin—Pulmonary oedema—Gemcitabine—lung cancer	0.00234	0.00463	CcSEcCtD
Terlipressin—Skin exfoliation—Cisplatin—lung cancer	0.00234	0.00463	CcSEcCtD
Terlipressin—Respiratory failure—Paclitaxel—lung cancer	0.00224	0.00443	CcSEcCtD
Terlipressin—Nervous system disorder—Pemetrexed—lung cancer	0.00223	0.00441	CcSEcCtD
Terlipressin—Dyspnoea—Crizotinib—lung cancer	0.00222	0.00439	CcSEcCtD
Terlipressin—Nervous system disorder—Gefitinib—lung cancer	0.00221	0.00438	CcSEcCtD
Terlipressin—Skin disorder—Pemetrexed—lung cancer	0.00221	0.00437	CcSEcCtD
Terlipressin—Skin disorder—Gefitinib—lung cancer	0.00219	0.00434	CcSEcCtD
Terlipressin—Acute coronary syndrome—Vinblastine—lung cancer	0.00217	0.0043	CcSEcCtD
Terlipressin—Myocardial infarction—Vinblastine—lung cancer	0.00216	0.00427	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Crizotinib—lung cancer	0.00215	0.00425	CcSEcCtD
Terlipressin—Skin exfoliation—Etoposide—lung cancer	0.00214	0.00424	CcSEcCtD
Terlipressin—Skin exfoliation—Paclitaxel—lung cancer	0.0021	0.00416	CcSEcCtD
Terlipressin—Acute coronary syndrome—Erlotinib—lung cancer	0.00209	0.00413	CcSEcCtD
Terlipressin—Myocardial infarction—Erlotinib—lung cancer	0.00207	0.00411	CcSEcCtD
Terlipressin—Dyspnoea—Pemetrexed—lung cancer	0.00203	0.00401	CcSEcCtD
Terlipressin—Dyspnoea—Gefitinib—lung cancer	0.00201	0.00398	CcSEcCtD
Terlipressin—Hyponatraemia—Irinotecan—lung cancer	0.00197	0.00389	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Pemetrexed—lung cancer	0.00196	0.00388	CcSEcCtD
Terlipressin—Cardiac failure—Gemcitabine—lung cancer	0.00196	0.00387	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Gefitinib—lung cancer	0.00195	0.00386	CcSEcCtD
Terlipressin—Hypertension—Teniposide—lung cancer	0.00195	0.00385	CcSEcCtD
Terlipressin—Chest pain—Teniposide—lung cancer	0.00192	0.0038	CcSEcCtD
Terlipressin—Respiratory failure—Docetaxel—lung cancer	0.0019	0.00376	CcSEcCtD
Terlipressin—Cyanosis—Methotrexate—lung cancer	0.0019	0.00376	CcSEcCtD
Terlipressin—Acute coronary syndrome—Vinorelbine—lung cancer	0.0018	0.00357	CcSEcCtD
Terlipressin—Tachycardia—Teniposide—lung cancer	0.0018	0.00355	CcSEcCtD
Terlipressin—Abdominal pain—Pemetrexed—lung cancer	0.0018	0.00355	CcSEcCtD
Terlipressin—Myocardial infarction—Vinorelbine—lung cancer	0.00179	0.00355	CcSEcCtD
Terlipressin—Hyponatraemia—Cisplatin—lung cancer	0.00179	0.00353	CcSEcCtD
Terlipressin—Abdominal pain—Gefitinib—lung cancer	0.00179	0.00353	CcSEcCtD
Terlipressin—Skin exfoliation—Docetaxel—lung cancer	0.00178	0.00352	CcSEcCtD
Terlipressin—Angiopathy—Topotecan—lung cancer	0.00174	0.00345	CcSEcCtD
Terlipressin—Hot flush—Paclitaxel—lung cancer	0.00171	0.00338	CcSEcCtD
Terlipressin—Diarrhoea—Crizotinib—lung cancer	0.0017	0.00337	CcSEcCtD
Terlipressin—Menopausal symptoms—Paclitaxel—lung cancer	0.00169	0.00335	CcSEcCtD
Terlipressin—Atrial fibrillation—Paclitaxel—lung cancer	0.00169	0.00334	CcSEcCtD
Terlipressin—Malnutrition—Topotecan—lung cancer	0.00167	0.00331	CcSEcCtD
Terlipressin—Cardiac failure—Etoposide—lung cancer	0.00167	0.0033	CcSEcCtD
Terlipressin—Pulmonary oedema—Docetaxel—lung cancer	0.00166	0.00328	CcSEcCtD
Terlipressin—Malnutrition—Erlotinib—lung cancer	0.00165	0.00327	CcSEcCtD
Terlipressin—Dyspnoea—Teniposide—lung cancer	0.00164	0.00325	CcSEcCtD
Terlipressin—Cardiac failure—Paclitaxel—lung cancer	0.00164	0.00324	CcSEcCtD
Terlipressin—Hyponatraemia—Paclitaxel—lung cancer	0.0016	0.00317	CcSEcCtD
Terlipressin—Vomiting—Crizotinib—lung cancer	0.00158	0.00313	CcSEcCtD
Terlipressin—Diarrhoea—Pemetrexed—lung cancer	0.00156	0.00308	CcSEcCtD
Terlipressin—Diarrhoea—Gefitinib—lung cancer	0.00155	0.00306	CcSEcCtD
Terlipressin—Cardiac disorder—Vinorelbine—lung cancer	0.00152	0.00302	CcSEcCtD
Terlipressin—Angiopathy—Vinorelbine—lung cancer	0.00149	0.00295	CcSEcCtD
Terlipressin—Acute coronary syndrome—Irinotecan—lung cancer	0.00149	0.00294	CcSEcCtD
Terlipressin—Hypertension—Vinblastine—lung cancer	0.00149	0.00294	CcSEcCtD
Terlipressin—Myocardial infarction—Irinotecan—lung cancer	0.00148	0.00293	CcSEcCtD
Terlipressin—Nausea—Crizotinib—lung cancer	0.00148	0.00292	CcSEcCtD
Terlipressin—Abdominal pain—Teniposide—lung cancer	0.00146	0.00288	CcSEcCtD
Terlipressin—Acute coronary syndrome—Gemcitabine—lung cancer	0.00145	0.00287	CcSEcCtD
Terlipressin—Hot flush—Docetaxel—lung cancer	0.00145	0.00286	CcSEcCtD
Terlipressin—Vomiting—Pemetrexed—lung cancer	0.00145	0.00286	CcSEcCtD
Terlipressin—Myocardial infarction—Gemcitabine—lung cancer	0.00144	0.00285	CcSEcCtD
Terlipressin—Vomiting—Gefitinib—lung cancer	0.00144	0.00284	CcSEcCtD
Terlipressin—Menopausal symptoms—Docetaxel—lung cancer	0.00143	0.00284	CcSEcCtD
Terlipressin—Malnutrition—Vinorelbine—lung cancer	0.00143	0.00283	CcSEcCtD
Terlipressin—Atrial fibrillation—Docetaxel—lung cancer	0.00143	0.00283	CcSEcCtD
Terlipressin—Chest pain—Topotecan—lung cancer	0.00142	0.00282	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—lung cancer	0.00141	0.0028	CcSEcCtD
Terlipressin—Chest pain—Erlotinib—lung cancer	0.00141	0.00279	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—lung cancer	0.0014	0.00277	CcSEcCtD
Terlipressin—Cardiac failure—Docetaxel—lung cancer	0.00139	0.00274	CcSEcCtD
Terlipressin—Bradycardia—Irinotecan—lung cancer	0.00138	0.00273	CcSEcCtD
Terlipressin—Respiratory failure—Methotrexate—lung cancer	0.00137	0.00271	CcSEcCtD
Terlipressin—Hyponatraemia—Docetaxel—lung cancer	0.00136	0.00269	CcSEcCtD
Terlipressin—Acute coronary syndrome—Cisplatin—lung cancer	0.00135	0.00267	CcSEcCtD
Terlipressin—Nausea—Pemetrexed—lung cancer	0.00135	0.00267	CcSEcCtD
Terlipressin—Myocardial infarction—Cisplatin—lung cancer	0.00134	0.00266	CcSEcCtD
Terlipressin—Nausea—Gefitinib—lung cancer	0.00134	0.00265	CcSEcCtD
Terlipressin—Nervous system disorder—Topotecan—lung cancer	0.00134	0.00265	CcSEcCtD
Terlipressin—Skin disorder—Topotecan—lung cancer	0.00133	0.00262	CcSEcCtD
Terlipressin—Nervous system disorder—Erlotinib—lung cancer	0.00132	0.00262	CcSEcCtD
Terlipressin—Skin disorder—Erlotinib—lung cancer	0.00131	0.00259	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Doxorubicin—lung cancer	0.00129	0.00255	CcSEcCtD
Terlipressin—Skin exfoliation—Methotrexate—lung cancer	0.00128	0.00254	CcSEcCtD
Terlipressin—Diarrhoea—Teniposide—lung cancer	0.00126	0.00249	CcSEcCtD
Terlipressin—Cardiac disorder—Irinotecan—lung cancer	0.00126	0.00249	CcSEcCtD
Terlipressin—Bradycardia—Cisplatin—lung cancer	0.00125	0.00248	CcSEcCtD
Terlipressin—Acute coronary syndrome—Etoposide—lung cancer	0.00124	0.00245	CcSEcCtD
Terlipressin—Hypertension—Vinorelbine—lung cancer	0.00123	0.00244	CcSEcCtD
Terlipressin—Myocardial infarction—Etoposide—lung cancer	0.00123	0.00243	CcSEcCtD
Terlipressin—Angiopathy—Irinotecan—lung cancer	0.00123	0.00243	CcSEcCtD
Terlipressin—Cardiac disorder—Gemcitabine—lung cancer	0.00122	0.00242	CcSEcCtD
Terlipressin—Chest pain—Vinorelbine—lung cancer	0.00122	0.00241	CcSEcCtD
Terlipressin—Dyspnoea—Topotecan—lung cancer	0.00122	0.00241	CcSEcCtD
Terlipressin—Acute coronary syndrome—Paclitaxel—lung cancer	0.00121	0.0024	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.00121	0.00239	CcSEcCtD
Terlipressin—Myocardial infarction—Paclitaxel—lung cancer	0.00121	0.00239	CcSEcCtD
Terlipressin—Dyspnoea—Erlotinib—lung cancer	0.0012	0.00238	CcSEcCtD
Terlipressin—Angiopathy—Gemcitabine—lung cancer	0.0012	0.00237	CcSEcCtD
Terlipressin—Pulmonary oedema—Methotrexate—lung cancer	0.0012	0.00237	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Topotecan—lung cancer	0.00118	0.00233	CcSEcCtD
Terlipressin—Vomiting—Teniposide—lung cancer	0.00117	0.00232	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Erlotinib—lung cancer	0.00117	0.00231	CcSEcCtD
Terlipressin—Headache—Teniposide—lung cancer	0.00115	0.00228	CcSEcCtD
Terlipressin—Nervous system disorder—Vinorelbine—lung cancer	0.00114	0.00226	CcSEcCtD
Terlipressin—Cardiac disorder—Cisplatin—lung cancer	0.00114	0.00226	CcSEcCtD
Terlipressin—Tachycardia—Vinorelbine—lung cancer	0.00114	0.00225	CcSEcCtD
Terlipressin—Skin disorder—Vinorelbine—lung cancer	0.00113	0.00224	CcSEcCtD
Terlipressin—Bradycardia—Paclitaxel—lung cancer	0.00113	0.00223	CcSEcCtD
Terlipressin—Skin exfoliation—Doxorubicin—lung cancer	0.00111	0.0022	CcSEcCtD
Terlipressin—Abdominal pain—Vinblastine—lung cancer	0.00111	0.0022	CcSEcCtD
Terlipressin—Nausea—Teniposide—lung cancer	0.00109	0.00216	CcSEcCtD
Terlipressin—Abdominal pain—Topotecan—lung cancer	0.00108	0.00213	CcSEcCtD
Terlipressin—Malnutrition—Cisplatin—lung cancer	0.00107	0.00212	CcSEcCtD
Terlipressin—Abdominal pain—Erlotinib—lung cancer	0.00107	0.00211	CcSEcCtD
Terlipressin—Cardiac disorder—Etoposide—lung cancer	0.00105	0.00207	CcSEcCtD
Terlipressin—Dyspnoea—Vinorelbine—lung cancer	0.00104	0.00206	CcSEcCtD
Terlipressin—Pulmonary oedema—Doxorubicin—lung cancer	0.00104	0.00205	CcSEcCtD
Terlipressin—Acute coronary syndrome—Docetaxel—lung cancer	0.00103	0.00204	CcSEcCtD
Terlipressin—Cardiac disorder—Paclitaxel—lung cancer	0.00103	0.00203	CcSEcCtD
Terlipressin—Myocardial infarction—Docetaxel—lung cancer	0.00102	0.00202	CcSEcCtD
Terlipressin—Angiopathy—Etoposide—lung cancer	0.00102	0.00202	CcSEcCtD
Terlipressin—Hypertension—Irinotecan—lung cancer	0.00102	0.00201	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Vinorelbine—lung cancer	0.00101	0.00199	CcSEcCtD
Terlipressin—Angiopathy—Paclitaxel—lung cancer	0.001	0.00198	CcSEcCtD
Terlipressin—Hypertension—Gemcitabine—lung cancer	0.000992	0.00196	CcSEcCtD
Terlipressin—Chest pain—Gemcitabine—lung cancer	0.000978	0.00194	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000971	0.00192	CcSEcCtD
Terlipressin—Malnutrition—Paclitaxel—lung cancer	0.000962	0.0019	CcSEcCtD
Terlipressin—Diarrhoea—Vinblastine—lung cancer	0.000961	0.0019	CcSEcCtD
Terlipressin—Nervous system disorder—Irinotecan—lung cancer	0.000944	0.00187	CcSEcCtD
Terlipressin—Diarrhoea—Topotecan—lung cancer	0.000934	0.00185	CcSEcCtD
Terlipressin—Diarrhoea—Erlotinib—lung cancer	0.000924	0.00183	CcSEcCtD
Terlipressin—Abdominal pain—Vinorelbine—lung cancer	0.000923	0.00183	CcSEcCtD
Terlipressin—Nervous system disorder—Gemcitabine—lung cancer	0.00092	0.00182	CcSEcCtD
Terlipressin—Skin disorder—Gemcitabine—lung cancer	0.000911	0.0018	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000905	0.00179	CcSEcCtD
Terlipressin—Hot flush—Doxorubicin—lung cancer	0.000903	0.00179	CcSEcCtD
Terlipressin—Menopausal symptoms—Doxorubicin—lung cancer	0.000896	0.00177	CcSEcCtD
Terlipressin—Vomiting—Vinblastine—lung cancer	0.000893	0.00177	CcSEcCtD
Terlipressin—Headache—Vinblastine—lung cancer	0.00088	0.00174	CcSEcCtD
Terlipressin—Cardiac disorder—Docetaxel—lung cancer	0.000869	0.00172	CcSEcCtD
Terlipressin—Vomiting—Topotecan—lung cancer	0.000868	0.00172	CcSEcCtD
Terlipressin—Cardiac failure—Doxorubicin—lung cancer	0.000866	0.00171	CcSEcCtD
Terlipressin—Vomiting—Erlotinib—lung cancer	0.000858	0.0017	CcSEcCtD
Terlipressin—Dyspnoea—Irinotecan—lung cancer	0.000858	0.0017	CcSEcCtD
Terlipressin—Nervous system disorder—Cisplatin—lung cancer	0.000857	0.0017	CcSEcCtD
Terlipressin—Headache—Topotecan—lung cancer	0.000855	0.00169	CcSEcCtD
Terlipressin—Tachycardia—Cisplatin—lung cancer	0.000853	0.00169	CcSEcCtD
Terlipressin—Angiopathy—Docetaxel—lung cancer	0.00085	0.00168	CcSEcCtD
Terlipressin—Skin disorder—Cisplatin—lung cancer	0.000849	0.00168	CcSEcCtD
Terlipressin—Hyponatraemia—Doxorubicin—lung cancer	0.000848	0.00168	CcSEcCtD
Terlipressin—Hypertension—Etoposide—lung cancer	0.000847	0.00168	CcSEcCtD
Terlipressin—Headache—Erlotinib—lung cancer	0.000846	0.00167	CcSEcCtD
Terlipressin—Dyspnoea—Gemcitabine—lung cancer	0.000836	0.00165	CcSEcCtD
Terlipressin—Chest pain—Etoposide—lung cancer	0.000835	0.00165	CcSEcCtD
Terlipressin—Nausea—Vinblastine—lung cancer	0.000834	0.00165	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Irinotecan—lung cancer	0.000831	0.00164	CcSEcCtD
Terlipressin—Hypertension—Paclitaxel—lung cancer	0.000831	0.00164	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.00083	0.00164	CcSEcCtD
Terlipressin—Chest pain—Paclitaxel—lung cancer	0.000819	0.00162	CcSEcCtD
Terlipressin—Malnutrition—Docetaxel—lung cancer	0.000815	0.00161	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000813	0.00161	CcSEcCtD
Terlipressin—Nausea—Topotecan—lung cancer	0.000811	0.0016	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Gemcitabine—lung cancer	0.00081	0.0016	CcSEcCtD
Terlipressin—Nausea—Erlotinib—lung cancer	0.000802	0.00159	CcSEcCtD
Terlipressin—Diarrhoea—Vinorelbine—lung cancer	0.000799	0.00158	CcSEcCtD
Terlipressin—Tachycardia—Etoposide—lung cancer	0.000782	0.00155	CcSEcCtD
Terlipressin—Dyspnoea—Cisplatin—lung cancer	0.000779	0.00154	CcSEcCtD
Terlipressin—Skin disorder—Etoposide—lung cancer	0.000778	0.00154	CcSEcCtD
Terlipressin—Nervous system disorder—Paclitaxel—lung cancer	0.00077	0.00152	CcSEcCtD
Terlipressin—Tachycardia—Paclitaxel—lung cancer	0.000766	0.00152	CcSEcCtD
Terlipressin—Skin disorder—Paclitaxel—lung cancer	0.000763	0.00151	CcSEcCtD
Terlipressin—Abdominal pain—Irinotecan—lung cancer	0.000761	0.00151	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Cisplatin—lung cancer	0.000755	0.00149	CcSEcCtD
Terlipressin—Vomiting—Vinorelbine—lung cancer	0.000742	0.00147	CcSEcCtD
Terlipressin—Headache—Vinorelbine—lung cancer	0.000731	0.00145	CcSEcCtD
Terlipressin—Dyspnoea—Etoposide—lung cancer	0.000714	0.00141	CcSEcCtD
Terlipressin—Hypertension—Docetaxel—lung cancer	0.000704	0.00139	CcSEcCtD
Terlipressin—Dyspnoea—Paclitaxel—lung cancer	0.0007	0.00138	CcSEcCtD
Terlipressin—Chest pain—Docetaxel—lung cancer	0.000694	0.00137	CcSEcCtD
Terlipressin—Nausea—Vinorelbine—lung cancer	0.000693	0.00137	CcSEcCtD
Terlipressin—Desmopressin—PTGS2—lung cancer	0.000692	0.028	CrCbGaD
Terlipressin—Gastrointestinal disorder—Etoposide—lung cancer	0.000691	0.00137	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000689	0.00136	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000678	0.00134	CcSEcCtD
Terlipressin—Diarrhoea—Irinotecan—lung cancer	0.000659	0.0013	CcSEcCtD
Terlipressin—Nervous system disorder—Docetaxel—lung cancer	0.000653	0.00129	CcSEcCtD
Terlipressin—Tachycardia—Docetaxel—lung cancer	0.000649	0.00128	CcSEcCtD
Terlipressin—Skin disorder—Docetaxel—lung cancer	0.000646	0.00128	CcSEcCtD
Terlipressin—Diarrhoea—Gemcitabine—lung cancer	0.000642	0.00127	CcSEcCtD
Terlipressin—Abdominal pain—Etoposide—lung cancer	0.000633	0.00125	CcSEcCtD
Terlipressin—Cardiac disorder—Methotrexate—lung cancer	0.000627	0.00124	CcSEcCtD
Terlipressin—Abdominal pain—Paclitaxel—lung cancer	0.000621	0.00123	CcSEcCtD
Terlipressin—Angiopathy—Methotrexate—lung cancer	0.000613	0.00121	CcSEcCtD
Terlipressin—Vomiting—Irinotecan—lung cancer	0.000612	0.00121	CcSEcCtD
Terlipressin—Headache—Irinotecan—lung cancer	0.000603	0.00119	CcSEcCtD
Terlipressin—Diarrhoea—Cisplatin—lung cancer	0.000598	0.00118	CcSEcCtD
Terlipressin—Vomiting—Gemcitabine—lung cancer	0.000596	0.00118	CcSEcCtD
Terlipressin—Bradycardia—Doxorubicin—lung cancer	0.000595	0.00118	CcSEcCtD
Terlipressin—Dyspnoea—Docetaxel—lung cancer	0.000593	0.00117	CcSEcCtD
Terlipressin—Malnutrition—Methotrexate—lung cancer	0.000588	0.00116	CcSEcCtD
Terlipressin—Headache—Gemcitabine—lung cancer	0.000587	0.00116	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Docetaxel—lung cancer	0.000575	0.00114	CcSEcCtD
Terlipressin—Nausea—Irinotecan—lung cancer	0.000572	0.00113	CcSEcCtD
Terlipressin—Nausea—Gemcitabine—lung cancer	0.000557	0.0011	CcSEcCtD
Terlipressin—Vomiting—Cisplatin—lung cancer	0.000556	0.0011	CcSEcCtD
Terlipressin—Diarrhoea—Etoposide—lung cancer	0.000548	0.00108	CcSEcCtD
Terlipressin—Cardiac disorder—Doxorubicin—lung cancer	0.000543	0.00107	CcSEcCtD
Terlipressin—Diarrhoea—Paclitaxel—lung cancer	0.000537	0.00106	CcSEcCtD
Terlipressin—Angiopathy—Doxorubicin—lung cancer	0.00053	0.00105	CcSEcCtD
Terlipressin—Abdominal pain—Docetaxel—lung cancer	0.000526	0.00104	CcSEcCtD
Terlipressin—Nausea—Cisplatin—lung cancer	0.000519	0.00103	CcSEcCtD
Terlipressin—Vomiting—Etoposide—lung cancer	0.000509	0.00101	CcSEcCtD
Terlipressin—Malnutrition—Doxorubicin—lung cancer	0.000509	0.00101	CcSEcCtD
Terlipressin—Headache—Etoposide—lung cancer	0.000502	0.000992	CcSEcCtD
Terlipressin—Chest pain—Methotrexate—lung cancer	0.0005	0.00099	CcSEcCtD
Terlipressin—Vomiting—Paclitaxel—lung cancer	0.000499	0.000988	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000497	0.000983	CcSEcCtD
Terlipressin—Headache—Paclitaxel—lung cancer	0.000492	0.000973	CcSEcCtD
Terlipressin—Nausea—Etoposide—lung cancer	0.000476	0.000941	CcSEcCtD
Terlipressin—Nervous system disorder—Methotrexate—lung cancer	0.00047	0.000931	CcSEcCtD
Terlipressin—Nausea—Paclitaxel—lung cancer	0.000466	0.000923	CcSEcCtD
Terlipressin—Skin disorder—Methotrexate—lung cancer	0.000466	0.000922	CcSEcCtD
Terlipressin—Diarrhoea—Docetaxel—lung cancer	0.000455	0.000901	CcSEcCtD
Terlipressin—Hypertension—Doxorubicin—lung cancer	0.000439	0.000869	CcSEcCtD
Terlipressin—Chest pain—Doxorubicin—lung cancer	0.000433	0.000857	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.00043	0.000851	CcSEcCtD
Terlipressin—Dyspnoea—Methotrexate—lung cancer	0.000428	0.000846	CcSEcCtD
Terlipressin—Vomiting—Docetaxel—lung cancer	0.000423	0.000837	CcSEcCtD
Terlipressin—Headache—Docetaxel—lung cancer	0.000417	0.000825	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Methotrexate—lung cancer	0.000414	0.000819	CcSEcCtD
Terlipressin—Nervous system disorder—Doxorubicin—lung cancer	0.000407	0.000806	CcSEcCtD
Terlipressin—Tachycardia—Doxorubicin—lung cancer	0.000405	0.000802	CcSEcCtD
Terlipressin—Skin disorder—Doxorubicin—lung cancer	0.000403	0.000798	CcSEcCtD
Terlipressin—Nausea—Docetaxel—lung cancer	0.000395	0.000782	CcSEcCtD
Terlipressin—Abdominal pain—Methotrexate—lung cancer	0.000379	0.00075	CcSEcCtD
Terlipressin—Dyspnoea—Doxorubicin—lung cancer	0.00037	0.000733	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000359	0.000709	CcSEcCtD
Terlipressin—Abdominal pain—Doxorubicin—lung cancer	0.000328	0.00065	CcSEcCtD
Terlipressin—Diarrhoea—Methotrexate—lung cancer	0.000328	0.000649	CcSEcCtD
Terlipressin—Vomiting—Methotrexate—lung cancer	0.000305	0.000603	CcSEcCtD
Terlipressin—Headache—Methotrexate—lung cancer	0.0003	0.000594	CcSEcCtD
Terlipressin—Nausea—Methotrexate—lung cancer	0.000285	0.000564	CcSEcCtD
Terlipressin—Diarrhoea—Doxorubicin—lung cancer	0.000284	0.000562	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—GNG11—lung cancer	0.000269	0.000603	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CG—lung cancer	0.000268	0.0006	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CXCL8—lung cancer	0.000266	0.000597	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AVP—lung cancer	0.000266	0.000596	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000265	0.000595	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CXCL8—lung cancer	0.000264	0.000592	CbGpPWpGaD
Terlipressin—Vomiting—Doxorubicin—lung cancer	0.000264	0.000522	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—AVP—lung cancer	0.000264	0.000591	CbGpPWpGaD
Terlipressin—Headache—Doxorubicin—lung cancer	0.00026	0.000515	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CD—lung cancer	0.000259	0.000581	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFC—lung cancer	0.000258	0.000578	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000258	0.000577	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFC—lung cancer	0.000256	0.000574	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—POMC—lung cancer	0.000255	0.000571	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STK11—lung cancer	0.00025	0.000561	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6R—lung cancer	0.000249	0.000557	CbGpPWpGaD
Terlipressin—Nausea—Doxorubicin—lung cancer	0.000247	0.000488	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—ADCY1—lung cancer	0.000244	0.000546	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ADCY1—lung cancer	0.000242	0.000542	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FOXO3—lung cancer	0.000242	0.000542	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ALB—lung cancer	0.000241	0.000541	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PPP2R1B—lung cancer	0.000237	0.000532	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SMARCA4—lung cancer	0.000237	0.000532	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—MAP2K1—lung cancer	0.000237	0.000531	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PPP2R1B—lung cancer	0.000236	0.000528	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SMARCA4—lung cancer	0.000236	0.000528	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CD—lung cancer	0.000235	0.000528	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HSPB1—lung cancer	0.000229	0.000513	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HSPB1—lung cancer	0.000227	0.00051	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AVP—lung cancer	0.000227	0.000508	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTHLH—lung cancer	0.000227	0.000508	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CB—lung cancer	0.000226	0.000506	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTHLH—lung cancer	0.000225	0.000504	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—RAF1—lung cancer	0.000218	0.000489	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF1R—lung cancer	0.000218	0.000489	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCL8—lung cancer	0.000217	0.000487	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HES1—lung cancer	0.000214	0.00048	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ANXA1—lung cancer	0.000213	0.000477	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ANXA1—lung cancer	0.000211	0.000474	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—RAF1—lung cancer	0.00021	0.000471	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—IL2—lung cancer	0.000207	0.000465	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FLT1—lung cancer	0.000206	0.000462	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CB—lung cancer	0.000205	0.00046	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FLT1—lung cancer	0.000205	0.000459	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CG—lung cancer	0.000204	0.000458	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CG—lung cancer	0.000203	0.000455	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APP—lung cancer	0.000202	0.000453	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOTCH3—lung cancer	0.000202	0.000453	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APP—lung cancer	0.0002	0.000449	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOTCH3—lung cancer	0.0002	0.000449	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGF9—lung cancer	0.0002	0.000449	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGF9—lung cancer	0.000199	0.000446	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CXCL8—lung cancer	0.000197	0.000442	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ERBB3—lung cancer	0.000196	0.000439	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—POMC—lung cancer	0.000194	0.000436	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—POMC—lung cancer	0.000193	0.000433	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—JUNB—lung cancer	0.000191	0.000429	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—JUNB—lung cancer	0.00019	0.000425	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL2—lung cancer	0.000188	0.000422	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TERT—lung cancer	0.000188	0.000421	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CG—lung cancer	0.000186	0.000416	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CG—lung cancer	0.000184	0.000413	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FGFR1—lung cancer	0.000182	0.000409	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CD—lung cancer	0.00018	0.000403	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HIF1A—lung cancer	0.000179	0.000402	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CD—lung cancer	0.000178	0.0004	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—POMC—lung cancer	0.000177	0.000396	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—POMC—lung cancer	0.000175	0.000393	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STK11—lung cancer	0.000174	0.000389	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APOA1—lung cancer	0.000173	0.000388	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STK11—lung cancer	0.000172	0.000386	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6R—lung cancer	0.000172	0.000386	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KDR—lung cancer	0.000172	0.000385	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6R—lung cancer	0.000171	0.000383	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FOXO3—lung cancer	0.000168	0.000376	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FOXO3—lung cancer	0.000166	0.000373	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAP2K1—lung cancer	0.000164	0.000368	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CD—lung cancer	0.000163	0.000366	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAP2K1—lung cancer	0.000163	0.000365	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CD—lung cancer	0.000162	0.000363	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APC—lung cancer	0.000158	0.000354	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CG—lung cancer	0.000158	0.000354	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KIT—lung cancer	0.000158	0.000354	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—NRAS—lung cancer	0.000158	0.000354	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AVP—lung cancer	0.000157	0.000352	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CB—lung cancer	0.000157	0.000351	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGF—lung cancer	0.000156	0.00035	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AVP—lung cancer	0.000156	0.000349	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CB—lung cancer	0.000155	0.000348	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—MAPK3—lung cancer	0.000151	0.000339	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF1R—lung cancer	0.000151	0.000339	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—POMC—lung cancer	0.000151	0.000337	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCL8—lung cancer	0.00015	0.000337	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF1R—lung cancer	0.00015	0.000336	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCL8—lung cancer	0.000149	0.000335	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—BRAF—lung cancer	0.000149	0.000333	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HES1—lung cancer	0.000148	0.000333	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HES1—lung cancer	0.000147	0.00033	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6R—lung cancer	0.000147	0.000329	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CREBBP—lung cancer	0.000147	0.000329	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—RAF1—lung cancer	0.000146	0.000326	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—RAF1—lung cancer	0.000145	0.000324	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—EGFR—lung cancer	0.000144	0.000323	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—IL2—lung cancer	0.000144	0.000322	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL2—lung cancer	0.000143	0.00032	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CB—lung cancer	0.000142	0.000319	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CB—lung cancer	0.000141	0.000316	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAP2K1—lung cancer	0.00014	0.000314	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CD—lung cancer	0.000139	0.000312	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CA—lung cancer	0.000138	0.000309	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCL8—lung cancer	0.000137	0.000306	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—KRAS—lung cancer	0.000136	0.000305	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB3—lung cancer	0.000136	0.000304	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCL8—lung cancer	0.000136	0.000304	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB3—lung cancer	0.000135	0.000302	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL2—lung cancer	0.000131	0.000293	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TERT—lung cancer	0.00013	0.000292	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL2—lung cancer	0.00013	0.000291	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TERT—lung cancer	0.000129	0.00029	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGFR1—lung cancer	0.000126	0.000283	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGFR1—lung cancer	0.000125	0.000281	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CA—lung cancer	0.000125	0.00028	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MDM2—lung cancer	0.000125	0.000279	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HIF1A—lung cancer	0.000124	0.000279	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RAF1—lung cancer	0.000124	0.000278	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HIF1A—lung cancer	0.000124	0.000277	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ERBB2—lung cancer	0.000123	0.000275	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MTOR—lung cancer	0.000121	0.000272	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CB—lung cancer	0.000121	0.000272	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APOA1—lung cancer	0.00012	0.000269	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APOA1—lung cancer	0.000119	0.000267	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KDR—lung cancer	0.000119	0.000267	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KDR—lung cancer	0.000118	0.000265	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCL8—lung cancer	0.000116	0.000261	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—HRAS—lung cancer	0.000116	0.000259	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—AKT1—lung cancer	0.000112	0.000252	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CASP3—lung cancer	0.000111	0.00025	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL2—lung cancer	0.000111	0.000249	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—lung cancer	0.000111	0.000248	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CG—lung cancer	0.00011	0.000246	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APC—lung cancer	0.00011	0.000246	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KIT—lung cancer	0.00011	0.000246	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—NRAS—lung cancer	0.00011	0.000246	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CG—lung cancer	0.000109	0.000244	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APC—lung cancer	0.000109	0.000244	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KIT—lung cancer	0.000109	0.000244	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—NRAS—lung cancer	0.000109	0.000244	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCND1—lung cancer	0.000108	0.000243	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGF—lung cancer	0.000108	0.000243	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—JUN—lung cancer	0.000108	0.000243	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGF—lung cancer	0.000108	0.000241	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP9—lung cancer	0.000105	0.000236	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAPK3—lung cancer	0.000105	0.000235	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1A—lung cancer	0.000105	0.000235	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTEN—lung cancer	0.000105	0.000235	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—POMC—lung cancer	0.000104	0.000234	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAPK3—lung cancer	0.000104	0.000234	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—POMC—lung cancer	0.000104	0.000232	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—BRAF—lung cancer	0.000103	0.000231	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—BRAF—lung cancer	0.000102	0.000229	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—AKT1—lung cancer	0.000102	0.000229	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6R—lung cancer	0.000102	0.000228	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CREBBP—lung cancer	0.000102	0.000228	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6R—lung cancer	0.000101	0.000227	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CREBBP—lung cancer	0.000101	0.000226	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—EGFR—lung cancer	9.99e-05	0.000224	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EP300—lung cancer	9.99e-05	0.000224	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—EGFR—lung cancer	9.91e-05	0.000222	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SRC—lung cancer	9.71e-05	0.000218	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAP2K1—lung cancer	9.7e-05	0.000217	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CD—lung cancer	9.64e-05	0.000216	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAP2K1—lung cancer	9.63e-05	0.000216	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CD—lung cancer	9.57e-05	0.000214	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CA—lung cancer	9.54e-05	0.000214	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CA—lung cancer	9.48e-05	0.000212	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—lung cancer	9.46e-05	0.000212	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—KRAS—lung cancer	9.43e-05	0.000211	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—KRAS—lung cancer	9.37e-05	0.00021	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STAT3—lung cancer	9.36e-05	0.00021	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NRAS—lung cancer	9.34e-05	0.000209	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK3—lung cancer	8.95e-05	0.000201	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—lung cancer	8.7e-05	0.000195	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CA—lung cancer	8.67e-05	0.000194	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MDM2—lung cancer	8.63e-05	0.000194	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CA—lung cancer	8.6e-05	0.000193	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RAF1—lung cancer	8.6e-05	0.000193	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MDM2—lung cancer	8.57e-05	0.000192	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RAF1—lung cancer	8.54e-05	0.000191	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB2—lung cancer	8.51e-05	0.000191	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGFR—lung cancer	8.51e-05	0.000191	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB2—lung cancer	8.45e-05	0.000189	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MTOR—lung cancer	8.4e-05	0.000188	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CB—lung cancer	8.4e-05	0.000188	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CB—lung cancer	8.34e-05	0.000187	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MTOR—lung cancer	8.34e-05	0.000187	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCL8—lung cancer	8.07e-05	0.000181	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KRAS—lung cancer	8.04e-05	0.00018	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—HRAS—lung cancer	8.02e-05	0.00018	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCL8—lung cancer	8.01e-05	0.00018	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—HRAS—lung cancer	7.96e-05	0.000178	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKT1—lung cancer	7.8e-05	0.000175	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKT1—lung cancer	7.74e-05	0.000174	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP3—lung cancer	7.72e-05	0.000173	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2—lung cancer	7.71e-05	0.000173	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—lung cancer	7.67e-05	0.000172	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP3—lung cancer	7.67e-05	0.000172	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2—lung cancer	7.66e-05	0.000172	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—lung cancer	7.62e-05	0.000171	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCND1—lung cancer	7.52e-05	0.000169	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—JUN—lung cancer	7.5e-05	0.000168	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCND1—lung cancer	7.47e-05	0.000167	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—JUN—lung cancer	7.45e-05	0.000167	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CA—lung cancer	7.39e-05	0.000166	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP9—lung cancer	7.3e-05	0.000164	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1A—lung cancer	7.27e-05	0.000163	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTEN—lung cancer	7.26e-05	0.000163	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP9—lung cancer	7.25e-05	0.000162	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1A—lung cancer	7.22e-05	0.000162	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTEN—lung cancer	7.21e-05	0.000162	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—lung cancer	7.15e-05	0.00016	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT1—lung cancer	7.08e-05	0.000159	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT1—lung cancer	7.03e-05	0.000158	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EP300—lung cancer	6.92e-05	0.000155	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EP300—lung cancer	6.87e-05	0.000154	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HRAS—lung cancer	6.83e-05	0.000153	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SRC—lung cancer	6.73e-05	0.000151	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SRC—lung cancer	6.68e-05	0.00015	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—lung cancer	6.56e-05	0.000147	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—lung cancer	6.54e-05	0.000147	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—lung cancer	6.51e-05	0.000146	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT3—lung cancer	6.49e-05	0.000145	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NRAS—lung cancer	6.47e-05	0.000145	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT3—lung cancer	6.44e-05	0.000144	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NRAS—lung cancer	6.43e-05	0.000144	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK3—lung cancer	6.2e-05	0.000139	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK3—lung cancer	6.16e-05	0.000138	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT1—lung cancer	6.03e-05	0.000135	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—lung cancer	6.03e-05	0.000135	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—lung cancer	5.99e-05	0.000134	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGFR—lung cancer	5.9e-05	0.000132	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGFR—lung cancer	5.86e-05	0.000131	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KRAS—lung cancer	5.57e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KRAS—lung cancer	5.53e-05	0.000124	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CA—lung cancer	5.12e-05	0.000115	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CA—lung cancer	5.08e-05	0.000114	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—lung cancer	4.95e-05	0.000111	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—lung cancer	4.92e-05	0.00011	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HRAS—lung cancer	4.74e-05	0.000106	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HRAS—lung cancer	4.7e-05	0.000105	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—lung cancer	4.53e-05	0.000102	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—lung cancer	4.5e-05	0.000101	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT1—lung cancer	4.18e-05	9.38e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT1—lung cancer	4.15e-05	9.31e-05	CbGpPWpGaD
